Drug Type Small molecule drug |
Synonyms |
Target- |
Action- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular ischemia | Phase 2 | United States | 30 Jul 2021 | |
Diabetic macular ischemia | Phase 2 | United Kingdom | 30 Jul 2021 | |
Diabetic macular ischemia | Phase 2 | Latvia | 30 Jul 2021 | |
Diabetic macular ischemia | Phase 2 | Australia | 30 Jul 2021 | |
Diabetic macular ischemia | Phase 2 | Netherlands | 30 Jul 2021 | |
Diabetic macular ischemia | Phase 2 | Spain | 30 Jul 2021 |
Phase 1/2 | 46 | (cccgmuynla) = hujlfrixdr xfyerzpuxw (nfpufdxfvn ) View more | Positive | 19 Sep 2024 | |||
BI 765128 medium dose | (cccgmuynla) = waklqtzwmt xfyerzpuxw (nfpufdxfvn ) View more | ||||||
Phase 1/2 | 46 | (Single Rising Dose Part: Low-dose BI 765128) | zmblejtasv(vkrezlblke) = imawdmoetw gjloyhbwgw (btzdgynuvg, kravaadfqk - bfdluhxdag) View more | - | 27 Aug 2024 | ||
(Single Rising Dose Part: Medium-dose BI 765128) | zmblejtasv(vkrezlblke) = kawmxvchwm gjloyhbwgw (btzdgynuvg, ktdvvbddpv - qoxusucged) View more |